Radiopharmaceuticals ( DrugBank: - )

---

1 disease

ID	Disease name (Link within this page)	Number of trials
5	Progressive supranuclear palsy	2

5. Progressive supranuclear palsy

---

Clinical trials : 95 /  Drugs : 119 - (DrugBank : 40) / Drug target genes : 65 - Drug target pathways : 108

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03926702 (ClinicalTrials.gov)	June 18, 2019	22/4/2019	Tau Imaging With JNJ067	Tau Imaging With JNJ067	Alzheimer Disease;Mild Cognitive Impairment;Progressive Supranuclear Palsy	Drug: Radiopharmaceuticals	University of California, Berkeley	University of California, San Francisco	Active, not recruiting	50 Years	N/A	All	18	Early Phase 1	United States
2	NCT02167594 (ClinicalTrials.gov)	August 12, 2014	17/6/2014	Tau Imaging in Subjects With Progressive Supranuclear Palsy, Corticobasal Degeneration and Healthy Volunteers	18F-AV-1451 Injection for Brain Imaging of Tau in Subjects With Progressive Supranuclear Palsy (PSP), Subjects With Corticobasal Degeneration (CBD) and Healthy Volunteers	Progressive Supranuclear Palsy;Corticobasal Degeneration	Drug: Flortaucipir F18;Procedure: Brain PET scan	Avid Radiopharmaceuticals	NULL	Completed	50 Years	85 Years	All	29	Phase 1	United States